The United Laboratories International Holdings Limited (FRA:UNJ)

Market Cap	2.53B -6.3%
Revenue (ttm)	1.68B +0.7%
Net Income	364.03M +5.3%
EPS	0.20 +5.3%
Shares Out	n/a
PE Ratio	6.95
Forward PE	7.73
Dividend	0.07 (5.34%)
Ex-Dividend Date	Sep 25, 2025

Volume	n/a
Average Volume	141
Open	1.250
Previous Close	1.250
Day's Range	1.250 - 1.250
52-Week Range	1.220 - 2.000
Beta	n/a
RSI	45.35
Earnings Date	Mar 26, 2026

About FRA:UNJ

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 17,400
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UNJ

Financial Performance

In 2024, FRA:UNJ's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY